Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Library license
March 2017
SHARING OPTIONS:

CAMBRIDGE, U.K.—Isogenica Ltd. and Maverick Therapeutics, an MPM Capital portfolio company, have joined forces in a license agreement centered around Isogenica’s family of antibody libraries. Per the deal, Maverick has received a license to Isogenica’s llamdA VHH single-domain antibody libraries for the discovery, development and commercialization of therapeutic products derived from the libraries. In return, Isogenica stands to receive an upfront payment as well as annual license payments and, should antibodies be moved into development, additional commercial upfront and milestone payments. No specific financial details were disclosed. Isogenica’s libraries can be screened in a variety of formats, including phage and CIS-Display, a proprietary in-vitro display technology that maintains the libraries’ diversity through the discovery process.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.